Literature DB >> 6494233

Hemodynamic effects of two ergot derivatives in the conscious spontaneously hypertensive rat.

D Susić, N Djordjević, D Kentera.   

Abstract

The effect of acute and chronic administration of two ergot derivatives, dihydroergosine (DHESN) and ergosinine (ESNN), on blood pressure, heart rate, cardiac output and total peripheral resistance was studied in conscious spontaneously hypertensive rats. Acute administration of either DHESN or ESNN (50-100 micrograms/kg) resulted in prompt and significant (p less than 0.01) decrease of both blood pressure and heart rate, which lasted for more than 12 h. The decrease in blood pressure was due to reduction in total peripheral resistance, as cardiac output remained unchanged. Prolonged treatment (50 micrograms/kg, i.p., every second day for 12 days) with either DHESN or ESNN significantly (p less than 0.01) decreased blood pressure. In chronically treated rats, total peripheral resistance was found to be decreased while no changes in cardiac output and heart rate were observed. The results indicate that both DHESN and ESNN are potent antihypertensive agents, due to their vasodilator effects. The hypotensive effect of DHESN could be partially blocked by haloperidol, but not by yohimbine. Both, DHESN and ESNN antagonized the effect of phenylephrine on blood pressure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6494233     DOI: 10.1159/000138016

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  3 in total

1.  Bioavailability of dihydroergosine in healthy volunteers.

Authors:  P Cvelbar; J Culig; Z Kopitar; A Lenardic; J U Smerkolj; M Zorz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jan-Mar       Impact factor: 2.441

2.  Effect of dihydroergosine (DHESN) on the serotoninergic system and behaviour: is DHESN a new antidepressive agent?

Authors:  D Pericić; H Manev; S Levanat; B Jernej; D Vujić; N Djordjević
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  An Overview of Bioactive 1,3-Oxazole-Containing Alkaloids from Marine Organisms.

Authors:  Jinyun Chen; Sunyan Lv; Jia Liu; Yanlei Yu; Hong Wang; Huawei Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.